Skip to main content

Study: Oregon Would Double Marijuana Supply If All Producer Licenses Allotted

A new study of the economics of Oregon’s recreational cannabis industry shows the state would nearly double its cannabis supply if regulators approved all pending producer applications, which could potentially strain an already glutted market.

Oregon’s market has struggled with oversupply issues, driving prices down for adult-use cannabis growers and attracting pressure from federal regulators concerned about diversion of cannabis out of state.

The study, released Wednesday, suggests the oversupply situation is unlikely to change anytime soon.

The report comes as state regulators and policymakers have raised the idea of imposing caps on the number of business licenses and curbing – or even reducing – canopy size limits for growers.

Here are some key findings from the biennial Recreational Marijuana Supply and Demand Legislative Report, conducted by the Oregon Liquor Control Commission, which regulates the state’s marijuana program:

  • Between July 2017 and June 2018, recreational cannabis demand represented 50% of supply; the other 50% remained accounted for in recreational licensees’ inventory and contained within the recreational system.
  • Licensed recreational producers harvested more than 2,000 metric tons of wet, untrimmed marijuana in 2018; if all currently pending producer applications were approved, estimated production would increase to nearly 4,000 metric tons of wet weight.
  • As of Jan. 1, 2019, the recreational market has 6½ years worth of theoretical supply in licensees’ inventory accounted for and contained within Oregon’s cannabis tracking system.
  • An estimated 55% of total statewide marijuana consumption among Oregonians 21 or older is procured from recreational cannabis retailers versus the black market. Based on existing levels of production, all consumption of marijuana among Oregon adults could be supplied by the legal market.
  • Increased supply has resulted in consumer prices falling from more than $10 per gram of marijuana in October 2016 to less than $5 per gram in December 2018. Despite those falling prices, the overall sales have continued to increase year-over-year, rising nearly 16% between December 2017 and December 2018.

The report also notes that “even under assumptions of growth in demand caused by more Oregonians consuming more marijuana, supply will almost certainly continue to exceed demand at current levels of production.”

Original Article Source: https://mjbizdaily.com/study-oregon-would-double-marijuana-supply-if-all-producer-licenses-allotted/

Comments

Post a Comment

Popular posts from this blog

Feds Hire Hazmat Firm For Marijuana Eradication Training

An ambitious campaign to decriminalize psychedelics in Washington, D.C., is one step closer to placing their measure on the November ballot with the formal submission of tens of thousands of voter signatures. Organizers have been scrambling for weeks to collect enough signatures from D.C. voters by Monday’s deadline amid historically difficult circumstances: a global pandemic, months of stay-at-home orders and protests over racism and police violence that filled the streets of the nation’s capital. But with the help of innovative signature-gathering techniques and allies flown in from across the country, advocates said they had successfully submitted upwards of 35,000 signatures—more than enough to qualify the initiative. If approved by voters, Initiative 81 would make enforcement of laws against plant- and fungus-based psychedelics among the “lowest law enforcement priorities” for the Metropolitan Police Department. It would not, however, legalize or reduce penalties for the substa...
Post a Comment
Read more

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties. Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes. Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outc...
Post a Comment
Read more

FDA Warns 15 Companies For Illegally Selling CBD Products

The agency also released a consumer update about CBD , the non-psychoactive ingredient in marijuana increasingly used to treat pain and anxiety. Until it learns more about the effectiveness and safety of CBD, the FDA said it cannot generally recognize the ingredient as safe or approve products that contain it. “We remain concerned that some people wrongly think that the myriad of CBD products on the market, many of which are illegal, have been evaluated by the FDA and determined to be safe, or that trying CBD ‘can’t hurt,‘” FDA Principal Deputy Commissioner Amy Abernethy said. The FDA sent letters to the following 15 companies for selling CBD products that violate the Food, Drug and Cosmetic Act, for marketing the products to treat illnesses or for therapeutic use, claiming it’s a dietary supplement or adding it to food for humans and animals. -Red Pill Medical Inc. of Phoenix, Arizona -Pink Collections Inc. of Beverly Hills, California -Healthy Hemp Strategies LLC (does ...
Post a Comment
Read more